IBBQ Holdings
Invesco Nasdaq Biotechnology ETF
1W: -1.9%
1M: -5.4%
3M: +2.3%
YTD: +21.0%
1Y: +37.6%
3Y: +75.8%
5Y: +34.2%
$34.37
-0.05 (-0.15%)
Weekly Expected Move ±3.0%
$32
$33
$34
$35
$36
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
ETF-Level Metrics
AUM$81M
Holdings247
Top 10 Wt45.4%
Beta0.61
% Profitable24%
Coverage100%
Portfolio Valuation
P/E40.7
P/B7.9
P/S6.7
EV/EBITDA26.5
P/FCF22.0
PEG3.15
Profitability & Returns
Gross Margin76.1%
Net Margin9.8%
ROE11.5%
ROA4.4%
ROIC10.2%
Div Yield0.54%
Leverage & Liquidity
Debt/Equity1.05
Debt/Assets0.39
Net Debt/EBITDA1.8x
Interest Cov4.5x
Current Ratio1.83
Quick Ratio1.53
Growth (YoY)
Revenue+28.8%
Net Income+6.7%
EPS+10.9%
FCF+21.7%
EBITDA+10.8%
Rev CAGR 3Y+36.7%
Quality Scores
Piotroski F5.0
Altman Z12.17
IS Quality60.3
IS Overall54.8
IS Value38.8
Median P/E-5.2
Sector Breakdown
3 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 246 | 100.0% | -6.0 |
| Financial Services | 1 | 0.0% | — |
| Other | 10 | 0.0% | — |
Smart Money Overlap
1 holdings with signals| Symbol | Company | Weight % | Signals | Badge | Insider Buys | Congress | Since Signal |
|---|---|---|---|---|---|---|---|
| AMLX | Amylyx Pharmaceuticals, Inc. | 0.24% | 3 | Bullish | 1 | 0 | +99.5% |
Showing 50 of 257 holdings
· Page 1 of 6
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | Gilead Sciences Inc | GILD | 8.16% | $8.8M | 59,068 | -55.7 | $179.5B | Healthcare |
| 2 | Amgen Inc | AMGN | 7.85% | $8.5M | 20,117 | 24.8 | $217.5B | Healthcare |
| 3 | Vertex Pharmaceuticals Inc | VRTX | 7.69% | $8.3M | 15,881 | 29.1 | $128.1B | Healthcare |
| 4 | Moderna Inc | MRNA | 5.04% | $5.4M | 28,250 | -23.8 | $75.4B | Healthcare |
| 5 | Regeneron Pharmaceuticals Inc | REGN | 5.02% | $5.4M | 7,153 | 17.6 | $75.7B | Healthcare |
| 6 | Revolution Medicines Inc | RVMD | 2.88% | $3.1M | 15,163 | -23.3 | $43.9B | Healthcare |
| 7 | Illumina Inc | ILMN | 2.71% | $2.9M | 10,685 | 50.5 | $41.3B | Healthcare |
| 8 | Biogen Inc | BIIB | 2.19% | $2.4M | 10,457 | 38.7 | $32.5B | Healthcare |
| 9 | Alnylam Pharmaceuticals Inc | ALNY | 2.16% | $2.3M | 9,468 | 36.0 | $29.4B | Healthcare |
| 10 | Roivant Sciences Ltd | ROIV | 1.73% | $1.9M | 51,097 | -94.0 | $25.8B | Healthcare |
| 11 | Argenx SE | ARGNF | 1.71% | $1.8M | 1,926 | 33.3 | $58.2B | Healthcare |
| 12 | Royalty Pharma PLC | RPRX | 1.70% | $1.8M | 31,502 | 23.7 | $25.3B | Healthcare |
| 13 | Insmed Inc | INSM | 1.63% | $1.8M | 15,452 | -27.0 | $24.1B | Healthcare |
| 14 | Incyte Corp | INCY | 1.61% | $1.7M | 14,343 | 14.2 | $23.4B | Healthcare |
| 15 | Guardant Health Inc | GH | 1.57% | $1.7M | 9,493 | -50.9 | $23.9B | Healthcare |
| 16 | United Therapeutics Corp | UTHR | 1.52% | $1.6M | 3,037 | 17.9 | $23.0B | Healthcare |
| 17 | Viatris Inc | VTRS | 1.33% | $1.4M | 81,239 | -48.9 | $20.5B | Healthcare |
| 18 | Medpace Holdings Inc | MEDP | 1.14% | $1.2M | 1,969 | 34.5 | $16.7B | Healthcare |
| 19 | Jazz Pharmaceuticals PLC | JAZZ | 0.98% | $1.1M | 4,592 | 15.5 | $14.8B | Healthcare |
| 20 | Exelixis Inc | EXEL | 0.95% | $1.0M | 17,520 | 17.7 | $14.7B | Healthcare |
| 21 | Neurocrine Biosciences Inc | NBIX | 0.94% | $1.0M | 7,190 | 20.3 | $14.4B | Healthcare |
| 22 | Tempus AI Inc | TEM | 0.94% | $1.0M | 12,405 | -53.6 | $13.4B | Healthcare |
| 23 | Ascendis Pharma A/S | ASND | 0.92% | $991,516 | 4,352 | 16.7 | $14.2B | Healthcare |
| 24 | Summit Therapeutics Inc | SMMT | 0.88% | $954,096 | 56,422 | -15.0 | $13.4B | Healthcare |
| 25 | Bridgebio Pharma Inc | BBIO | 0.86% | $932,583 | 14,173 | -18.8 | $13.2B | Healthcare |
| 26 | BeOne Medicines Ltd | ONC | 0.86% | $927,292 | 2,534 | 26.4 | $38.3B | Healthcare |
| 27 | Twist Bioscience Corp | TWST | 0.84% | $905,909 | 4,688 | -85.0 | $11.7B | Healthcare |
| 28 | Halozyme Therapeutics Inc | HALO | 0.82% | $885,629 | 8,022 | 31.2 | $13.0B | Healthcare |
| 29 | BioMarin Pharmaceutical Inc | BMRN | 0.76% | $822,060 | 13,701 | 150.5 | $11.1B | Healthcare |
| 30 | Madrigal Pharmaceuticals Inc | MDGL | 0.76% | $821,959 | 1,631 | -38.7 | $11.5B | Healthcare |
| 31 | BioNTech SE | BNTX | 0.75% | $805,863 | 8,198 | -12.7 | $24.3B | Healthcare |
| 32 | 10X Genomics Inc | TXG | 0.71% | $768,964 | 8,510 | -158.5 | $11.9B | Healthcare |
| 33 | ImmunityBio Inc | IBRX | 0.65% | $706,886 | 74,882 | -10.6 | $10.8B | Healthcare |
| 34 | Krystal Biotech Inc | KRYS | 0.65% | $697,711 | 2,098 | 39.0 | $9.5B | Healthcare |
| 35 | Axsome Therapeutics Inc | AXSM | 0.63% | $682,612 | 3,702 | -47.8 | $9.2B | Healthcare |
| 36 | Kymera Therapeutics Inc | KYMR | 0.61% | $656,766 | 5,875 | -33.0 | $8.8B | Healthcare |
| 37 | Arrowhead Pharmaceuticals Inc | ARWR | 0.61% | $654,696 | 10,003 | -28.7 | $9.0B | Healthcare |
| 38 | Cytokinetics Inc | CYTK | 0.60% | $647,961 | 9,831 | -9.1 | $8.2B | Healthcare |
| 39 | Protagonist Therapeutics Inc | PTGX | 0.60% | $645,135 | 4,579 | 115.0 | $9.0B | Healthcare |
| 40 | Sanofi SA | SNY | 0.58% | $629,005 | 15,256 | 21.7 | $95.9B | Healthcare |
| 41 | Caris Life Sciences Inc | CAI | 0.57% | $612,049 | 19,982 | 76.1 | $8.0B | Healthcare |
| 42 | Vaxcyte Inc | PCVX | 0.55% | $598,304 | 10,515 | -7.4 | $8.2B | Healthcare |
| 43 | Praxis Precision Medicines Inc | PRAX | 0.53% | $573,432 | 1,969 | -22.8 | $8.2B | Healthcare |
| 44 | Spyre Therapeutics Inc | SYRE | 0.51% | $554,301 | 6,226 | -47.8 | $8.1B | Healthcare |
| 45 | Ionis Pharmaceuticals Inc | IONS | 0.49% | $524,370 | 11,744 | -12.6 | $7.2B | Healthcare |
| 46 | Amneal Pharmaceuticals Inc | AMRX | 0.46% | $495,927 | 24,624 | 40.8 | $6.5B | Healthcare |
| 47 | Immunovant Inc | IMVT | 0.46% | $493,830 | 14,619 | -11.9 | $6.9B | Healthcare |
| 48 | Alkermes PLC | ALKS | 0.45% | $481,053 | 11,872 | 103.6 | $7.0B | Healthcare |
| 49 | Iovance Biotherapeutics Inc | IOVA | 0.44% | $474,581 | 32,023 | -20.3 | $6.3B | Healthcare |
| 50 | Rhythm Pharmaceuticals Inc | RYTM | 0.43% | $463,983 | 4,873 | -29.8 | $6.4B | Healthcare |